The present invention provides novel monoclonal antibodies directed to PlGF and fragments and derivatives thereof, more particularly to humanized antibodies and fragments thereof for use in the treatment and/or prevention of pathological angiogenesis.
申请公布号
KR20080016794(A)
申请公布日期
2008.02.22
申请号
KR20077024317
申请日期
2006.03.24
申请人
THROMBOGENICS N.V.;LIFE SCIENCES RESEARCH PARTNERS VZW;VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE
